Insmed Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -172.4% | -156.3% | -243.8% | -136.1% | -193.6% | -187.6% | -282.4% | -191.4% | -154.4% | -93.8% | -72.8% | -20.9% | -68.5% | |
| 3.5% | 3.3% | 3.8% | 3.0% | 2.9% | 2.6% | 3.4% | 3.5% | 2.8% | 2.1% | 1.6% | 1.2% | 1.7% | |
| 25.3% | 23.9% | 28.4% | 25.8% | 27.3% | 25.4% | 42.3% | 40.0% | 22.1% | 14.8% | 15.0% | 9.7% | 13.8% | |
| -30.3% | 9.2% | -73.0% | 43.8% | -16.8% | 26.9% | -71.2% | 8.9% | 9.8% | -14.3% | -21.0% | -5.9% | -9.9% | |
| 3.6% | 2.6% | 6.2% | 7.5% | 3.9% | 6.5% | 10.8% | 3.2% | 1.7% | 17.7% | 1.1% | 1.5% | 5.2% | |
| 9.0% | 2.2% | 391.2% | -7.5% | -1,074.1% | 126.2% | 86.6% | 212.1% | -535.5% | 147.6% | 86.8% | 5.8% | -7.3% | |
| – | – | – | – | -0.7% | 143.0% | -0.8% | -2.5% | -0.5% | -0.3% | -0.3% | -0.2% | -0.3% | |
| 1.6% | 147.3% | 4.0% | 865.1% | 425.2% | 152.5% | 31.2% | 798.6% | 23.5% | 12.8% | 9.6% | 6.4% | 10.9% | |
| -159.1% | -5.7% | 150.1% | 720.7% | -840.6% | 89.6% | -163.5% | 820.3% | -667.1% | 66.6% | 23.4% | -8.8% | -65.0% | |
| -176.0% | -158.9% | -250.0% | -143.6% | -197.6% | -194.1% | -293.2% | -194.6% | -156.1% | -111.5% | -73.9% | -22.3% | -73.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.